STOCK TITAN

Pedevco Financials

PED
FY2025 annual
Revenue $45.8M +15.7% YoY
Net Income -$10.4M -184.3% YoY
EPS (Diluted) -$2.25 YoY not available
Free Cash Flow Not reported for FY2025
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Pedevco (PED) reported $45.8M in revenue for fiscal year 2025, up 15.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI PED FY2025

FY2025 shifted the company from lightly leveraged operations to externally funded expansion with tighter liquidity and negative operating profitability.

Balance-sheet expansion came with a financing shift: total assets nearly tripled from FY2024 to FY2025 while debt-to-equity rose from 0.1x to 0.8x, indicating that growth required substantially more financial support. Current ratio then fell from 1.9x to 0.6x, so the enlarged asset base did not translate into comparable short-term flexibility.

Operating margin moved from 11.9% in FY2024 to -17.2% in FY2025, while SG&A reached $16.8M; the reversal points to a cost structure that expanded faster than operating earnings. EBITDA remained positive at $10.2M, but $18.0M of depreciation and amortization left the reported operating result negative, highlighting the burden of the asset base.

FY2025 produced operating cash flow of $10.8M despite a net loss of -$10.4M, showing that non-cash charges materially separated cash generation from accounting earnings. The company invested $133.2M while receiving $122.1M from financing, making capital deployment dependent on funding inflows rather than internally generated cash alone.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 45 / 100
Financial Health Score 45/100
Scored as: Energy peer group

Scored against energy companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Pedevco's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
12
Growth
85
Leverage
51
Liquidity
8
Cash Flow
99
Returns
16
Altman Z-Score Distress
0.14

Pedevco scores 0.14, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($176.5M) relative to total liabilities ($168.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/7

Pedevco passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed
N/A

Pedevco reported a net loss of $10.4M while generating $10.8M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Pedevco reported an operating loss of $7.9M against $1.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$45.8M
YoY+15.7%
5Y CAGR+41.5%

Pedevco generated $45.8M in revenue in fiscal year 2025. This represents an increase of 15.7% from the prior year.

EBITDA
$10.2M
YoY-50.8%

Pedevco's EBITDA was $10.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 50.8% from the prior year.

Net Income
-$10.4M
YoY-184.3%

Pedevco reported -$10.4M in net income in fiscal year 2025. This represents a decrease of 184.3% from the prior year.

EPS (Diluted)
-$2.25

Pedevco earned -$2.25 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Cash & Debt
$3.2M
YoY-19.7%
5Y CAGR-16.7%
10Y CAGR+11.0%

Pedevco held $3.2M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding
13M

Pedevco had 13M shares outstanding in fiscal year 2025.

Free Cash Flow

Not reported for fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Operating Margin
-17.2%
YoY-29.1pp

Pedevco's operating margin was -17.2% in fiscal year 2025, reflecting core business profitability. This is down 29.1 percentage points from the prior year.

Net Margin
-22.7%
YoY-53.7pp

Pedevco's net profit margin was -22.7% in fiscal year 2025, showing the share of revenue converted to profit. This is down 53.7 percentage points from the prior year.

Return on Equity
-5.0%
YoY-15.6pp
5Y CAGR+38.2pp

Pedevco's ROE was -5.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 15.6 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Capital Allocation

None of these metrics is reported for fiscal year 2025.

PED Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

PED quarterly income statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Revenue$46.1M+14.6%$40.2M+183.3%$14.2M+104.0%$7.0M-0.2%$7.0M-20.2%$8.7M-17.4%$10.6M+16.9%$9.1M
SG&A Expenses$3.4M+9.7%$3.1MN/A$1.5M-9.9%$1.7M+6.1%$1.6M-26.5%$2.2M+61.6%$1.3M
Operating Income$15.4M+129.1%$6.7MN/A-$834K+62.8%-$2.2M-1596.0%$150K+111.0%-$1.4M-148.4%$2.8M
Interest Expense$2.0M-1.1%$2.0MN/A$102K$0$0N/A$0
Income Tax$1.0M+218.3%-$868KN/A-$164K+66.5%-$490K-744.7%$76K+101.0%-$7.3M$0
Net Income$17.5M+168.1%-$25.6MN/A-$325K+80.6%-$1.7M-1297.1%$140K-97.6%$5.9M+103.2%$2.9M
EPS (Diluted)$1.31-$3.28-47.1%-$2.23$0.00+100.0%-$0.37-1333.3%$0.03$0.07+133.3%$0.03

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

PED Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

PED quarterly balance sheet
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Total Assets$359.7M-2.8%$370.1M-1.5%$375.9M+176.6%$135.9M-0.7%$136.8M-6.0%$145.6M+13.4%$128.3M+12.3%$114.3M
Current Assets$39.8M-6.4%$42.5M+12.7%$37.8M+133.7%$16.2M-8.2%$17.6M-25.4%$23.6M+78.5%$13.2M+20.3%$11.0M
Cash & Equivalents$10.8M+40.3%$7.7M+139.0%$3.2M-70.5%$10.9M+29.0%$8.5M-18.7%$10.4M+159.7%$4.0M-13.2%$4.6M
Inventory$141K0.0%$141K+131.1%$61KN/AN/AN/A$0N/A
Accounts Receivable$24.0M-12.4%$27.4M+6.8%$25.7M+413.1%$5.0M-41.5%$8.6M-27.8%$11.8M+48.2%$8.0M+50.2%$5.3M
Total Liabilities$159.6M-15.0%$187.9M+11.5%$168.5M+721.2%$20.5M+26.9%$16.2M-32.2%$23.9M+87.2%$12.7M+64.0%$7.8M
Current Liabilities$50.7M-19.4%$63.0M-2.3%$64.5M+340.5%$14.6M+38.5%$10.6M-37.5%$16.9M+144.8%$6.9M+32.2%$5.2M
Total Equity$200.1M+9.8%$182.2M-12.1%$207.4M+79.7%$115.4M+0.2%$115.2M-0.9%$116.2M+0.5%$115.6M+8.5%$106.5M
Retained Earnings-$130.0M+11.8%-$147.5M-21.0%-$121.9M-7.5%-$113.4M-5.4%-$107.5M-1.6%-$105.9M+5.1%-$111.5M+7.2%-$120.1M

Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.

PED Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

PED quarterly cash flow statement
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Operating Cash Flow$15.3M+45.6%$10.5M+590.7%-$2.1M-129.0%$7.4M+1861.2%-$420K-107.1%$5.9M+40.5%$4.2M-48.9%$8.3M
Investing Cash Flow-$1.5M+90.7%-$16.5M+87.0%-$127.2M-2473.9%-$4.9M-196.8%-$1.7M-366.4%$625K+113.1%-$4.8M+51.1%-$9.8M
Financing Cash Flow-$13.0M-218.7%$11.0M-91.0%$122.0M$0-100.0%$139K$0$0$0

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

PED Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

PED quarterly financial ratios
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24
Operating Margin33.3%+16.6pp16.7%N/A-12.0%+20.2pp-32.2%-33.9pp1.7%+14.7pp-12.9%-44.2pp31.3%
Net Margin37.9%+101.6pp-63.7%N/A-4.7%+19.4pp-24.0%-25.6pp1.6%-54.4pp56.0%+23.8pp32.2%
Return on Equity8.7%+22.8pp-14.1%N/A-0.3%+1.2pp-1.5%-1.6pp0.1%-5.0pp5.1%+2.4pp2.7%
Return on Assets4.9%+11.8pp-6.9%N/A-0.2%+1.0pp-1.2%-1.3pp0.1%-4.5pp4.6%+2.1pp2.5%
Current Ratio0.78+0.1x0.68+0.1x0.59-0.5x1.10-0.6x1.67+0.3x1.40-0.5x1.91-0.2x2.10
Debt-to-Equity0.80-0.2x1.03+0.2x0.81+0.6x0.180.0x0.14-0.1x0.21+0.1x0.110.0x0.07

Not reported in any period shown, so not listed: Gross Margin, FCF Margin.

Note: The current ratio is below 1.0 (0.59), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

What is Pedevco's annual revenue?

Pedevco (PED) reported $45.8M in total revenue for fiscal year 2025. This represents a 15.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Pedevco's revenue growing?

Pedevco (PED) revenue grew by 15.7% year-over-year, from $39.6M to $45.8M in fiscal year 2025.

Is Pedevco profitable?

No, Pedevco (PED) reported a net income of -$10.4M in fiscal year 2025, with a net profit margin of -22.7%.

Pedevco (PED) reported diluted earnings per share of -$2.25 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Pedevco (PED) had EBITDA of $10.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Pedevco (PED) had an operating margin of -17.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Pedevco (PED) had a net profit margin of -22.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Pedevco (PED) has a return on equity of -5.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Pedevco (PED) generated $10.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Pedevco (PED) had $375.9M in total assets as of fiscal year 2025, including both current and long-term assets.

Pedevco (PED) had 13M shares outstanding as of fiscal year 2025.

Pedevco (PED) had a current ratio of 0.59 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Pedevco (PED) had a debt-to-equity ratio of 0.81 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Pedevco (PED) had a return on assets of -2.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Pedevco (PED) has an Altman Z-Score of 0.14, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Pedevco (PED) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Pedevco (PED) reported a net loss of $10.4M while generating $10.8M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Pedevco (PED) reported an operating loss of $7.9M against $1.4M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Pedevco (PED) scores 45 out of 100 on our Financial Health Score, indicating moderate standing within its energy companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top